High-Content Analysis (HCA) or High-Content Screening (HCS) is a method for obtaining quantitative multi-parametric data from a single cell by combining high-throughput automated imaging with analysis. High-content screening is now established in a much broader area of the life science space as an impartial imaging method to assess cellular function. It was initially developed as a technology to complement conventional biochemical high-throughput screening (HTS) in drug discovery.When compared to high-content screening, high-content imaging (HCI) is typically defined as automated microscopy with a lower throughput (less than 100,000 samples or data points). However, the terms high-content screening and high-content analysis are frequently used interchangeably with high-content imaging.
Market dynamics :
High content screening is on the rise for screening , imaging and identification of molecular entities. For instance, in 2023, Cytiva, a biotechnology and lifesciences company, designed Typhoon laser-scanner platform for versatile imaging and precise quantitation of fluorescent, colorimetric, and radiolabeled nucleic acids and proteins. This was a line of Cytiva’s screening laser products that included Amersham Typhoon IP, Amersham Typhoon IP, Amersham Typhoon 5. Cytiva is Sglobal provider of technologies and services that advances and accelerates the development, manufacture, and delivery of therapeutics.
Key features of the study:
- This report provides in-depth analysis of the global high content screening market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global high content screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., GE HealthCare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher, Yokogawa Electric Corporation, Sysmex Corporation, and Thorlabs, Inc.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global high content screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global high content screening market
Detailed Segmentation:
- Global High Content Screening Market, By Product Type:
- Cell Imaging and Analysis Equipment
- Consumables
- HCS Software
- HCS Services
- Global High Content Screening Market, By Application:
- Primary Screening
- Target Identification & Validation
- Toxicity Studies
- Compound Profiling
- Others
- Global High Content Screening Market, By End User:
- Pharmaceutical Organizations
- Biotechnology Organizations
- Research Institutes
- Independent CRO
- Government Organizations
- Others
- Global High Content Screening Market, By Geography:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East:
- GCC
- Israel
- Rest of Middle East
- Africa
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- GE HealthCare
- Olympus Corporation
- PerkinElmer Inc.
- Merck Millipore Corporation
- Danaher
- Yokogawa Electric Corporation
- Sysmex Corporation
- Thorlabs, Inc.
